Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 52 entries
Sorted by: Best Match Show Resources per page
Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease.

Aging and disease

Maeso-Díaz R, Ortega-Ribera M, Lafoz E, Lozano JJ, Baiges A, Francés R, Albillos A, Peralta C, García-Pagán JC, Bosch J, Cogger VC, Gracia-Sancho J.
PMID: 31440376
Aging Dis. 2019 Aug 01;10(4):684-698. doi: 10.14336/AD.2019.0127. eCollection 2019 Aug.

Advanced chronic liver disease (aCLD) represents a major public health concern. aCLD is more prevalent and severe in the elderly, carrying a higher risk of decompensation. We aimed at understanding how aging may impact on the pathophysiology of aCLD...

Cite
Maeso-Díaz R, Ortega-Ribera M, Lafoz E, et al. Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease. Aging Dis. 2019;10(4):684-698doi: 10.14336/AD.2019.0127.
Maeso-Díaz, R., Ortega-Ribera, M., Lafoz, E., Lozano, J. J., Baiges, A., Francés, R., Albillos, A., Peralta, C., García-Pagán, J. C., Bosch, J., Cogger, V. C., & Gracia-Sancho, J. (2019). Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease. Aging and disease, 10(4), 684-698. https://doi.org/10.14336/AD.2019.0127
Maeso-Díaz, Raquel, et al. "Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease." Aging and disease vol. 10,4 (2019): 684-698. doi: https://doi.org/10.14336/AD.2019.0127
Maeso-Díaz R, Ortega-Ribera M, Lafoz E, Lozano JJ, Baiges A, Francés R, Albillos A, Peralta C, García-Pagán JC, Bosch J, Cogger VC, Gracia-Sancho J. Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease. Aging Dis. 2019 Aug 01;10(4):684-698. doi: 10.14336/AD.2019.0127. eCollection 2019 Aug. PMID: 31440376; PMCID: PMC6675529.
Copy Download .nbib Format: NLM
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).

Journal of hepatology

Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Albillos A, Francés R, Fernández-Rodríguez C, Diago M, Soriano G, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Estévez P, Hernandez-Guerra M, Augustín S, Bañales J, Aspichueta P, Benlloch S, Rosales JM, Salmerón J, Turnes J, Romero-Gómez M.
PMID: 32654856
J Hepatol. 2020 Sep;73(3):740-741. doi: 10.1016/j.jhep.2020.06.018. Epub 2020 Jul 09.

No abstract available.

Cite
Ampuero J, Aller R, Gallego-Durán R, et al. Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25). J Hepatol. 2020;73(3):740-741doi: 10.1016/j.jhep.2020.06.018.
Ampuero, J., Aller, R., Gallego-Durán, R., Crespo, J., Calleja, J. L., García-Monzón, C., Gómez-Camarero, J., Caballería, J., Lo Iacono, O., Ibañez, L., García-Samaniego, J., Albillos, A., Francés, R., Fernández-Rodríguez, C., Diago, M., Soriano, G., Andrade, R. J., Latorre, R., Jorquera, F., Morillas, R. M., Escudero, D., Estévez, P., Hernandez-Guerra, M., Augustín, S., Bañales, J., Aspichueta, P., Benlloch, S., Rosales, J. M., Salmerón, J., Turnes, J., Romero-Gómez, M. (2020). Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25). Journal of hepatology, 73(3), 740-741. https://doi.org/10.1016/j.jhep.2020.06.018
Ampuero, Javier, et al. "Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25)." Journal of hepatology vol. 73,3 (2020): 740-741. doi: https://doi.org/10.1016/j.jhep.2020.06.018
Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Albillos A, Francés R, Fernández-Rodríguez C, Diago M, Soriano G, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Estévez P, Hernandez-Guerra M, Augustín S, Bañales J, Aspichueta P, Benlloch S, Rosales JM, Salmerón J, Turnes J, Romero-Gómez M. Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25). J Hepatol. 2020 Sep;73(3):740-741. doi: 10.1016/j.jhep.2020.06.018. Epub 2020 Jul 09. PMID: 32654856.
Copy Download .nbib Format: NLM
Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity.

Therapeutic advances in gastroenterology

Bañares R, Ibáñez-Samaniego L, Torner JM, Pavesi M, Olmedo C, Catalina MV, Albillos A, Larsen FS, Nevens F, Hassanein T, Schmidt H, Heeman U, Jalan R, Moreau R, Arroyo V.
PMID: 31632458
Therap Adv Gastroenterol. 2019 Sep 27;12:1756284819879565. eCollection 2019.

BACKGROUND: Acute-on-chronic liver failure (ACLF) is a common complication of cirrhosis characterized by single or multiple organ failures and high short-term mortality. Treatment of ACLF consists of standard medical care (SMC) and organ(s) support. Whether the efficacy of artificial...

Cite
Bañares R, Ibáñez-Samaniego L, Torner JM, et al. Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity. Therap Adv Gastroenterol. 2019;12:1756284819879565
Bañares, R., Ibáñez-Samaniego, L., Torner, J. M., Pavesi, M., Olmedo, C., Catalina, M. V., Albillos, A., Larsen, F. S., Nevens, F., Hassanein, T., Schmidt, H., Heeman, U., Jalan, R., Moreau, R., & Arroyo, V. (2019). Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity. Therapeutic advances in gastroenterology, 121756284819879565.
Bañares, Rafael, et al. "Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity." Therapeutic advances in gastroenterology vol. 12 (2019): 1756284819879565.
Bañares R, Ibáñez-Samaniego L, Torner JM, Pavesi M, Olmedo C, Catalina MV, Albillos A, Larsen FS, Nevens F, Hassanein T, Schmidt H, Heeman U, Jalan R, Moreau R, Arroyo V. Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity. Therap Adv Gastroenterol. 2019 Sep 27;12:1756284819879565. eCollection 2019. PMID: 31632458; PMCID: PMC6767713.
Copy Download .nbib Format: NLM
A novel EUS-guided rescue therapy for non-drainable walled-off pancreatic necrosis.

Gastroenterologia y hepatologia

Sánchez Aldehuelo R, Albillos A, Vazquez-Sequeiros E.
PMID: 33746029
Gastroenterol Hepatol. 2021 Mar 19; doi: 10.1016/j.gastrohep.2021.01.015. Epub 2021 Mar 19.

No abstract available.

Cite
Sánchez Aldehuelo R, Albillos A, Vazquez-Sequeiros E. A novel EUS-guided rescue therapy for non-drainable walled-off pancreatic necrosis. Gastroenterol Hepatol. 2021;doi: 10.1016/j.gastrohep.2021.01.015.
Sánchez Aldehuelo, R., Albillos, A., & Vazquez-Sequeiros, E. (2021). A novel EUS-guided rescue therapy for non-drainable walled-off pancreatic necrosis. Gastroenterologia y hepatologia, . https://doi.org/10.1016/j.gastrohep.2021.01.015
Sánchez Aldehuelo, Rubén, et al. "A novel EUS-guided rescue therapy for non-drainable walled-off pancreatic necrosis." Gastroenterologia y hepatologia vol. (2021). doi: https://doi.org/10.1016/j.gastrohep.2021.01.015
Sánchez Aldehuelo R, Albillos A, Vazquez-Sequeiros E. A novel EUS-guided rescue therapy for non-drainable walled-off pancreatic necrosis. Gastroenterol Hepatol. 2021 Mar 19; doi: 10.1016/j.gastrohep.2021.01.015. Epub 2021 Mar 19. Spanish. PMID: 33746029.
Copy Download .nbib Format: NLM
Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature.

Cancers

Manicardi N, Fernández-Iglesias A, Abad-Jordà L, Royo F, Azkargorta M, Ortega-Ribera M, Sanfeliu-Redondo D, Martínez-Alcocer A, Elortza F, Hessheimer AJ, Fondevila C, Lozano JJ, García-Pagán JC, Bosch J, Cubero FJ, Albillos A, Vaquero J, Falcón-Pérez JM, Gracia-Sancho J.
PMID: 34072510
Cancers (Basel). 2021 May 29;13(11). doi: 10.3390/cancers13112688.

The poor prognosis of chronic liver disease (CLD) generates the need to investigate the evolving mechanisms of disease progression, thus disclosing therapeutic targets before development of clinical complications. Considering the central role of liver sinusoidal endothelial cells (LSECs) in...

Cite
Manicardi N, Fernández-Iglesias A, Abad-Jordà L, et al. Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature. Cancers (Basel). 2021;13(11)doi: 10.3390/cancers13112688.
Manicardi, N., Fernández-Iglesias, A., Abad-Jordà, L., Royo, F., Azkargorta, M., Ortega-Ribera, M., Sanfeliu-Redondo, D., Martínez-Alcocer, A., Elortza, F., Hessheimer, A. J., Fondevila, C., Lozano, J. J., García-Pagán, J. C., Bosch, J., Cubero, F. J., Albillos, A., Vaquero, J., Falcón-Pérez, J. M., & Gracia-Sancho, J. (2021). Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature. Cancers, 13(11), . https://doi.org/10.3390/cancers13112688
Manicardi, Nicolò, et al. "Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature." Cancers vol. 13,11 (2021). doi: https://doi.org/10.3390/cancers13112688
Manicardi N, Fernández-Iglesias A, Abad-Jordà L, Royo F, Azkargorta M, Ortega-Ribera M, Sanfeliu-Redondo D, Martínez-Alcocer A, Elortza F, Hessheimer AJ, Fondevila C, Lozano JJ, García-Pagán JC, Bosch J, Cubero FJ, Albillos A, Vaquero J, Falcón-Pérez JM, Gracia-Sancho J. Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature. Cancers (Basel). 2021 May 29;13(11). doi: 10.3390/cancers13112688. PMID: 34072510; PMCID: PMC8198220.
Copy Download .nbib Format: NLM
Crosstalk between α7 and α3β4 nicotinic receptors prevents their desensitization in human chromaffin cells.

The Journal of neuroscience : the official journal of the Society for Neuroscience

Jiménez-Pompa A, Sanz-Lázaro S, Omodolor RE, Medina-Polo J, González-Enguita C, Blázquez J, McIntosh JM, Albillos A.
PMID: 34965978
J Neurosci. 2021 Dec 17; doi: 10.1523/JNEUROSCI.1115-21.2021. Epub 2021 Dec 17.

The physical interaction and functional cross-talk among the different subtypes of neuronal nicotinic receptors (nAChRs) expressed in the various tissues is unknown. Here we have investigated this issue between the only two nAChRs subtypes expressed, the α7 and α3β4...

Cite
Jiménez-Pompa A, Sanz-Lázaro S, Omodolor RE, et al. Crosstalk between α7 and α3β4 nicotinic receptors prevents their desensitization in human chromaffin cells. J Neurosci. 2021;doi: 10.1523/JNEUROSCI.1115-21.2021.
Jiménez-Pompa, A., Sanz-Lázaro, S., Omodolor, R. E., Medina-Polo, J., González-Enguita, C., Blázquez, J., McIntosh, J. M., & Albillos, A. (2021). Crosstalk between α7 and α3β4 nicotinic receptors prevents their desensitization in human chromaffin cells. The Journal of neuroscience : the official journal of the Society for Neuroscience, . https://doi.org/10.1523/JNEUROSCI.1115-21.2021
Jiménez-Pompa, Amanda, et al. "Crosstalk between α7 and α3β4 nicotinic receptors prevents their desensitization in human chromaffin cells." The Journal of neuroscience : the official journal of the Society for Neuroscience vol. (2021). doi: https://doi.org/10.1523/JNEUROSCI.1115-21.2021
Jiménez-Pompa A, Sanz-Lázaro S, Omodolor RE, Medina-Polo J, González-Enguita C, Blázquez J, McIntosh JM, Albillos A. Crosstalk between α7 and α3β4 nicotinic receptors prevents their desensitization in human chromaffin cells. J Neurosci. 2021 Dec 17; doi: 10.1523/JNEUROSCI.1115-21.2021. Epub 2021 Dec 17. PMID: 34965978.
Copy Download .nbib Format: NLM
Can Plasma α-Synuclein Help Us to Differentiate Parkinson's Disease from Essential Tremor?.

Tremor and other hyperkinetic movements (New York, N.Y.)

Albillos SM, Montero O, Calvo S, Solano B, Trejo JM, Cubo E.
PMID: 34113478
Tremor Other Hyperkinet Mov (N Y). 2021 May 28;11:20. doi: 10.5334/tohm.600.

BACKGROUND: Studies have revealed controversial results regarding the diagnostic accuracy of plasma α-synuclein levels in patients with Parkinson's disease (PD). This study was aimed to analyze the diagnostic accuracy of plasma α-synuclein in PD versus healthy controls and patients...

Cite
Albillos SM, Montero O, Calvo S, et al. Can Plasma α-Synuclein Help Us to Differentiate Parkinson's Disease from Essential Tremor?. Tremor Other Hyperkinet Mov (N Y). 2021;11:20doi: 10.5334/tohm.600.
Albillos, S. M., Montero, O., Calvo, S., Solano, B., Trejo, J. M., & Cubo, E. (2021). Can Plasma α-Synuclein Help Us to Differentiate Parkinson's Disease from Essential Tremor?. Tremor and other hyperkinetic movements (New York, N.Y.), 1120. https://doi.org/10.5334/tohm.600
Albillos, Silvia M, et al. "Can Plasma α-Synuclein Help Us to Differentiate Parkinson's Disease from Essential Tremor?." Tremor and other hyperkinetic movements (New York, N.Y.) vol. 11 (2021): 20. doi: https://doi.org/10.5334/tohm.600
Albillos SM, Montero O, Calvo S, Solano B, Trejo JM, Cubo E. Can Plasma α-Synuclein Help Us to Differentiate Parkinson's Disease from Essential Tremor?. Tremor Other Hyperkinet Mov (N Y). 2021 May 28;11:20. doi: 10.5334/tohm.600. PMID: 34113478; PMCID: PMC8162285.
Copy Download .nbib Format: NLM
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.

Journal of hepatology

Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Brujats A, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J.
PMID: 33905794
J Hepatol. 2021 Sep;75(3):589-599. doi: 10.1016/j.jhep.2021.04.022. Epub 2021 Apr 24.

BACKGROUND & AIMS: The prognosis of compensated cirrhosis is good until decompensation. In decompensated cirrhosis, bacterial infections (BIs) are common and increase the risk of death. The incidence and prognostic implications of BIs in compensated cirrhosis are less-well characterized....

Cite
Villanueva C, Albillos A, Genescà J, et al. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. J Hepatol. 2021;75(3):589-599doi: 10.1016/j.jhep.2021.04.022.
Villanueva, C., Albillos, A., Genescà, J., Garcia-Pagan, J. C., Brujats, A., Calleja, J. L., Aracil, C., Bañares, R., Morillas, R. M., Poca, M., Peñas, B., Augustin, S., Abraldes, J. G., Alvarado, E., Torres, F., Bosch, J. (2021). Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. Journal of hepatology, 75(3), 589-599. https://doi.org/10.1016/j.jhep.2021.04.022
Villanueva, Càndid, et al. "Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis." Journal of hepatology vol. 75,3 (2021): 589-599. doi: https://doi.org/10.1016/j.jhep.2021.04.022
Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Brujats A, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. J Hepatol. 2021 Sep;75(3):589-599. doi: 10.1016/j.jhep.2021.04.022. Epub 2021 Apr 24. PMID: 33905794.
Copy Download .nbib Format: NLM
SARS-CoV-2 analysis on environmental surfaces collected in an intensive care unit: keeping Ernest Shackleton's spirit.

Intensive care medicine experimental

Escudero D, Boga JA, Fernández J, Forcelledo L, Balboa S, Albillos R, Astola I, García-Prieto E, Álvarez-Argüelles ME, Martín G, Jiménez J, Vázquez F.
PMID: 33225382
Intensive Care Med Exp. 2020 Nov 23;8(1):68. doi: 10.1186/s40635-020-00349-5.

BACKGROUND: Intensive care unit workers are at high risk of acquiring COVID-19 infection, especially when performing invasive techniques and certain procedures that generate aerosols (< 5 μm). Therefore, one of the objectives of the health systems should implement safety...

Cite
Escudero D, Boga JA, Fernández J, et al. SARS-CoV-2 analysis on environmental surfaces collected in an intensive care unit: keeping Ernest Shackleton's spirit. Intensive Care Med Exp. 2020;8(1):68doi: 10.1186/s40635-020-00349-5.
Escudero, D., Boga, J. A., Fernández, J., Forcelledo, L., Balboa, S., Albillos, R., Astola, I., García-Prieto, E., Álvarez-Argüelles, M. E., Martín, G., Jiménez, J., & Vázquez, F. (2020). SARS-CoV-2 analysis on environmental surfaces collected in an intensive care unit: keeping Ernest Shackleton's spirit. Intensive care medicine experimental, 8(1), 68. https://doi.org/10.1186/s40635-020-00349-5
Escudero, Dolores, et al. "SARS-CoV-2 analysis on environmental surfaces collected in an intensive care unit: keeping Ernest Shackleton's spirit." Intensive care medicine experimental vol. 8,1 (2020): 68. doi: https://doi.org/10.1186/s40635-020-00349-5
Escudero D, Boga JA, Fernández J, Forcelledo L, Balboa S, Albillos R, Astola I, García-Prieto E, Álvarez-Argüelles ME, Martín G, Jiménez J, Vázquez F. SARS-CoV-2 analysis on environmental surfaces collected in an intensive care unit: keeping Ernest Shackleton's spirit. Intensive Care Med Exp. 2020 Nov 23;8(1):68. doi: 10.1186/s40635-020-00349-5. PMID: 33225382; PMCID: PMC7680661.
Copy Download .nbib Format: NLM
Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349].

Gastroenterologia y hepatologia

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M.
PMID: 29929828
Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476. doi: 10.1016/j.gastrohep.2018.05.011.

No abstract available.

Cite
Aller R, Fernández-Rodríguez C, Lo Iacono O, et al. Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]. Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterol Hepatol. 2018;41(7):475-476doi: 10.1016/j.gastrohep.2018.05.011.
Aller, R., Fernández-Rodríguez, C., Lo Iacono, O., Bañares, R., Abad, J., Carrión, J. A., García-Monzón, C., Caballería, J., Berenguer, M., Rodríguez-Perálvarez, M., López Miranda, J., Vilar-Gómez, E., Crespo, J., García-Cortés, M., Reig, M., Navarro, J. M., Gallego-Durán, R., Genescà, J., Arias-Loste, M. T., Pareja, M. J., Albillos, A., Muntané, J., Jorquera, F., Solà, E., Hernández-Guerra, M., Rojo, M. �. �., Salmerón, J., Caballería, L., Diago, M., Molina, E., Bataller, R., & Romero-Gómez, M. (2018). Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]. Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterologia y hepatologia, 41(7), 475-476. https://doi.org/10.1016/j.gastrohep.2018.05.011
Aller, Rocío, et al. "Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]." Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterologia y hepatologia vol. 41,7 (2018): 475-476. doi: https://doi.org/10.1016/j.gastrohep.2018.05.011
Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M. Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]. Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476. doi: 10.1016/j.gastrohep.2018.05.011. Spanish. PMID: 29929828.
Copy Download .nbib Format: NLM
The multifactorial mechanisms of bacterial infection in decompensated cirrhosis.

Journal of hepatology

Van der Merwe S, Chokshi S, Bernsmeier C, Albillos A.
PMID: 34039494
J Hepatol. 2021 Jul;75:S82-S100. doi: 10.1016/j.jhep.2020.11.029.

Infections, due to a dysfunctional immune response, pose a great risk to patients with decompensated cirrhosis and herald the beginning of the terminal phase of this disease. Infections typically result from breaches in innate immune barriers and inadequate clearance...

Cite
Van der Merwe S, Chokshi S, Bernsmeier C, et al. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J Hepatol. 2021;75:S82-S100doi: 10.1016/j.jhep.2020.11.029.
Van der Merwe, S., Chokshi, S., Bernsmeier, C., & Albillos, A. (2021). The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. Journal of hepatology, 75S82-S100. https://doi.org/10.1016/j.jhep.2020.11.029
Van der Merwe, Schalk, et al. "The multifactorial mechanisms of bacterial infection in decompensated cirrhosis." Journal of hepatology vol. 75 (2021): S82-S100. doi: https://doi.org/10.1016/j.jhep.2020.11.029
Van der Merwe S, Chokshi S, Bernsmeier C, Albillos A. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J Hepatol. 2021 Jul;75:S82-S100. doi: 10.1016/j.jhep.2020.11.029. PMID: 34039494.
Copy Download .nbib Format: NLM
Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder.

Frontiers in psychiatry

Alvarez-Mon MA, Gomez-Lahoz AM, Orozco A, Lahera G, Sosa-Reina MD, Diaz D, Albillos A, Quintero J, Molero P, Monserrat J, Alvarez-Mon M.
PMID: 33488424
Front Psychiatry. 2021 Jan 08;11:591962. doi: 10.3389/fpsyt.2020.591962. eCollection 2020.

No abstract available.

Cite
Alvarez-Mon MA, Gomez-Lahoz AM, Orozco A, et al. Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder. Front Psychiatry. 2021;11:591962doi: 10.3389/fpsyt.2020.591962.
Alvarez-Mon, M. A., Gomez-Lahoz, A. M., Orozco, A., Lahera, G., Sosa-Reina, M. D., Diaz, D., Albillos, A., Quintero, J., Molero, P., Monserrat, J., & Alvarez-Mon, M. (2020). Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder. Frontiers in psychiatry, 11591962. https://doi.org/10.3389/fpsyt.2020.591962
Alvarez-Mon, Miguel Angel, et al. "Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder." Frontiers in psychiatry vol. 11 (2020): 591962. doi: https://doi.org/10.3389/fpsyt.2020.591962
Alvarez-Mon MA, Gomez-Lahoz AM, Orozco A, Lahera G, Sosa-Reina MD, Diaz D, Albillos A, Quintero J, Molero P, Monserrat J, Alvarez-Mon M. Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder. Front Psychiatry. 2021 Jan 08;11:591962. doi: 10.3389/fpsyt.2020.591962. eCollection 2020. PMID: 33488424; PMCID: PMC7820111.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 52 entries